ILGEN
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
841 E Fayette St, Syracuse, New York, 13...Phone Number
(917) 891-4943Website
www.ilgenbio.comRevenue
<$5 MillionIndustry
About ILGEN
Is ILGEN your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on ILGEN recently announced quarterly report
Product Launch: Get notified when ILGEN launches new products
Congratulate Masked Content for being promoted to Masked Content at ILGEN
Website visits: Recent activity has been detected on your website
Click to see if ILGEN had a recent Job posting/layoffs
Funding: Get notified immidiatlly once ILGEN has new funding data
ILGEN, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ILGEN has recently received funding, and reach out quickly before it becomes old news!
Check out if ILGEN is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ILGEN
Compare insights from companies similar to ILGEN, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ILGEN
Company Profile Activity
Activity Insights
ILGEN is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ILGEN is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ILGEN.
ILGEN Tech Stack
A closer look at the technologies used by ILGEN
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding ILGEN
ILGEN Inc. is a biopharmaceutical company focused on developing novel proprietary biotechnology, including a first-in-class, naturally occurring LAG3 checkpoint inhibitor. Their innovative technology enables the efficient generation of high-affinity fully human antibodies for therapeutic and diagnostic applications, targeting various conditions suc... Read More